Dr. Hyun Kim, MD

Dr. Kim practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Kim's NPI, 1467718379, was assigned on April 4, 2012. Dr. Kim holds Missouri license 2017014156.

Dr. Kim's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Kim's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Kim is also affiliated with Barnes-Jewish Hospital. The medical group on file is City of Hope. Dmand AI also links Dr. Kim to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kim is licensed in Missouri.

CMS data shows 1,220 Medicare services from Dr. Kim across 15 procedure codes in 2024, for 238 Medicare patients. Medicare paid $112,865 for them.

CMS counts 238 Medicare patients who saw Dr. Kim in 2024. The largest group is 65 to 74, with 119 patients. 69% of them have high blood pressure, and 64% have cancer. 13% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 70, with 66% women.

In 2024, Dr. Kim wrote 102 Medicare Part D claims for 44 patients. 94% of them were for generic drugs. CMS names the drug for 67 of them, across 3 drugs with 11 or more claims each, at $449 in total drug cost. In 2023, CMS named 150 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kim for performance year 2024, reported as part of a group. Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kim as offering telehealth.

Dmand AI links 45 papers to Dr. Kim, published from 2011 to 2024. 2016 was the busiest year, with 5. The most frequent topics are Bile Duct Neoplasms, Cholangiocarcinoma and Embolization, Therapeutic. Dr. Kim has published most often in Cardiovasc Intervent Radiol. Dr. Kim's most frequent co-authors are Hyun S. Kim, MD, Stacey M. Stein, MD and David Michael Schuster, MD.

CMS Open Payments shows 84 general payments to Dr. Kim from 11 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 51% of the total. Siemens Medical Solutions USA, Inc. paid the most, $65,067. It also lists 1 research payment totaling $3,614 in 2025.